Pinz Capital Management’s CareDx CDNA Stock Holding History

Pinz Capital Management’s Portfolio CDNA Stock Details CDNA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q3	–	Sell	-47,800	Closed	-$1.69M	–	130
2020 Q2	$1.69M	Buy	+47,800	New	+$1.36M	0.78%	57

Other funds holding CDNA

FAM

Fred Alger Management New York $22.8B AUM 64.63% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

WRF

Waddell & Reed Financial Overland Park, Kansas $48.6B AUM 84.78% 1-Year Est. Return

FLAM

First Light Asset Management Edina, Minnesota $1.12B AUM 114.45% 1-Year Est. Return

AIM

ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return

Pinz Capital Management's CDNA Position: Q3 2020 in Review

Pinz Capital Management sold out of CareDx (CDNA) in Q3 2020, closing a stake of 47,800 shares — an estimated $1.69M sold.

Pinz Capital Management first reported a position in CDNA in Q2 2020 and held it in 1 quarter. The position peaked at $1.69M in Q2 2020. 197 funds tracked by Wall St. Rank hold CDNA as of Q3 2020.

Pinz Capital Management reported no remaining CareDx position as of Q3 2020 after selling out during the quarter.
Pinz Capital Management sold 47,800 CareDx shares in Q3 2020, an estimated $1.69M.
Pinz Capital Management first reported a position in CareDx in Q2 2020 and held it in 1 quarter.
Pinz Capital Management's CareDx position peaked at $1.69M in Q2 2020.
197 funds tracked by Wall St. Rank held CareDx as of Q3 2020.

Based on Pinz Capital Management's 13F filing for Q3 2020, filed 16 Nov 2020.